|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 36.39 USD | 0.00% |
|
-0.08% | +40.61% |
| 10-30 | Viatris Begins $36.50 Per Share Cash Offer for Pacira BioSciences | MT |
| 10-09 | Pacira Biosciences' Acquisition by Viatris Unlikely to See Superior Bid, RBC Says | MT |
| Market Cap | 1.45B 1.3B 1.19B 1.08B 2.02B 138B 2.06B 14.25B 5.72B 72.45B 5.44B 5.33B 228B | P/E 2026 * |
56.6x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.51B 1.35B 1.24B 1.12B 2.1B 143B 2.14B 14.8B 5.94B 75.26B 5.65B 5.53B 237B | EV / Sales 2026 * |
2x | EV / Sales 2027 * | 1.65x |
| Free-Float |
80.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCRX | Delayed | |
CBOE
| PCRX | Real-time | |
|
Deutsche Boerse AG
| 82P | Delayed | |
|
Tradegate
| 82P | Real-time | |
|
Börse Stuttgart
| 82P | Delayed | |
|
Boerse Muenchen
| 82P | Real-time |
Last Transcript: Pacira BioSciences, Inc.
| 1 week | -0.08% | ||
| Current month | +45.27% | ||
| 1 month | +45.27% | ||
| 3 months | +34.93% | ||
| 6 months | +42.76% | ||
| Current year | +40.61% |
| 1 week | 36.35 |  | 36.45 |
| 1 month | 24.56 | | 36.66 |
| Current year | 18.8 | | 36.66 |
| 1 year | 18.8 | | 36.66 |
| 3 years | 11.16 | | 36.66 |
| 5 years | 11.16 | | 82.16 |
| 10 years | 11.16 | | 82.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Lee
CEO | Chief Executive Officer | 58 | 2024-01-01 |
Shawn Cross
DFI | Director of Finance/CFO | 58 | 2024-10-20 |
Anthony Molloy
CMP | Compliance Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
CHM | Chairman | 68 | 2025-01-27 |
Mark Froimson
BRD | Director/Board Member | 65 | 2017-06-14 |
| Director/Board Member | 63 | 2019-09-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Exercice | Controller/Auditor | 18,000 | 0.0452% | ||
| 8/17/26 | Sell | Chief Technology Officer | -3,040 | 0.0077% | ||
| 6/10/26 | Free | Director | 32,675 | 0.0831% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.08% | +71.09% | +30.99% | 1.45B | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.56% | +5.30% | +49.04% | +77.92% | 426.34B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.89% | +98.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 754M 676M 621M 563M 1.05B 71.62B 1.07B 7.41B 2.97B 37.68B 2.83B 2.77B 119B | 790M 708M 651M 590M 1.1B 75.01B 1.12B 7.76B 3.12B 39.46B 2.96B 2.9B 124B |
| Net income | 28.95M 25.93M 23.85M 21.61M 40.4M 2.75B 41.15M 284M 114M 1.45B 109M 106M 4.56B | 54.44M 48.76M 44.85M 40.64M 75.96M 5.17B 77.39M 535M 215M 2.72B 204M 200M 8.58B |
| Net Debt | 56.16M 50.29M 46.26M 41.92M 78.35M 5.33B 79.82M 552M 221M 2.8B 211M 206M 8.85B | -149M -133M -123M -111M -208M -14.13B -211M -1.46B -587M -7.43B -558M -546M -23.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$36.39 | 0.00% | 737,238 |
| 26-10-29 | US$36.39 | 0.00% | 618,950 |
| 26-10-28 | US$36.39 | -0.03% | 914,029 |
| 26-10-27 | US$36.40 | +0.05% | 471,792 |
| 26-10-26 | US$36.38 | -0.11% | 607,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCRX Stock
Select your edition
All financial news and data tailored to specific country editions
